Pterostilbene inhibits colorectal aberrant crypt foci (ACF) and colon carcinogenesis via suppression of multiple signal transduction pathways in azoxymethane-treated mice

Journal of Agricultural and Food Chemistry

Volumn 58, Issue 15, 2010, Pages 8833-8841

  Chiou, Yi Siou ^a   Tsai, Mei Ling ^a   Wang, Ying Jan ^b   Cheng, An Chin ^c   Lai, Wei Ming ^d   Badmaev, Vladimir ^e   Ho, Chi Tang ^f   Pan, Min Hsiung ^a  

^a NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^d KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e SABINSA CORPORATION   (United States)

^f RUTGERS UNIVERSITY   (United States)

Author keywords

aberrant crypt foci; adenomas; azoxymethane; Pterostilbene

Indexed keywords

ABERRANT CRYPT FOCI; ADENOMAS; ANTI-INFLAMMATION; ANTI-TUMOR AGENTS; APOPTOSIS; AZOXYMETHANE; CATENIN SIGNALING; COLON CARCINOGENESIS; CYCLIND1; DOWN-REGULATION; EGFR SIGNALING; FUNCTIONAL AGENTS; INHIBITORY EFFECT; INTRAPERITONEAL; MOLECULAR MECHANISM; PHOSPHATIDYLINOSITOL; PRENEOPLASTIC LESIONS; PTEROSTILBENE; RESVERATROL; SIGNAL TRANSDUCTION PATHWAYS; TRANSCRIPTIONAL ACTIVATIONS; TUMORIGENESIS; UP-REGULATION;

CELL DEATH; GENE EXPRESSION; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SIGNALING; TUMORS;

GENE EXPRESSION REGULATION;

AZOXYMETHANE; PTEROSTILBENE; STILBENE DERIVATIVE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; COLON; COLON TUMOR; DISEASE MODEL; DOWN REGULATION; DRUG EFFECT; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; AZOXYMETHANE; COLON; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HUMANS; MALE; MICE; MICE, INBRED ICR; SIGNAL TRANSDUCTION; STILBENES;

MUS;

EID: 77955679151     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf101571z     Document Type: Article

References (32)

1. Remsberg, C. M.; Yanez, J. A.; Ohgami, Y.; Vega-Villa, K. R.; Rimando, A. M.; Davies, N. M. Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity Phytother. Res. 2008, 22, 169-179
2. Pan, M. H.; Chang, Y. H.; Tsai, M. L.; Lai, C. S.; Ho, S. Y.; Badmaev, V.; Ho, C. T. Pterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages J. Agric. Food Chem. 2008, 56, 7502-7509
3. Pan, M. H.; Chang, Y. H.; Badmaev, V.; Nagabhushanam, K.; Ho, C. T. Pterostilbene induces apoptosis and cell cycle arrest in human gastric carcinoma cells J. Agric. Food Chem. 2007, 55, 7777-7785
4. Pan, M. H.; Chiou, Y. S.; Chen, W. J.; Wang, J. M.; Badmaev, V.; Ho, C. T. Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells Carcinogenesis 2009, 30, 1234-1242
5. Pan, M. H.; Lin, Y. T.; Lin, C. L.; Wei, C. S.; Ho, C. T.; Chen, W. J. Suppression of heregulin-β1/HER2-modulated invasive and aggressive phenotype of breast carcinoma by pterostilbene via inhibition of matrix metalloproteinase-9, p38 kinase cascade and Akt activation. Evidence-Based Complement Alternat. Med. 2009, DOI: 10.1093/ecam/nep093.
6. Suh, N.; Paul, S.; Hao, X.; Simi, B.; Xiao, H.; Rimando, A. M.; Reddy, B. S. Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats Clin. Cancer Res. 2007, 13 (1) 350-355
7. Paul, S.; DeCastro, A. J.; Lee, H. J.; Smolarek., A. K.; So, J. Y.; Simi, B.; Wang, C. X.; Zhou, R.; Rimando, A. M.; Suh, N. Dietary intake of pterostilbene, a constituent of blueberries, inhibits the β-catenin/p65 downstream signaling pathway and colon carcinogenesis Carcinogenesis 2010, 31, 1273-1278
8. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M. J. Cancer statistics, 2008 CA Cancer J. Clin. 2008, 58, 71-96
9. Fearon, E. R.; Vogelstein, B. A genetic model for colorectal tumorigenesis Cell 1990, 61, 759-767
10. Volate, S. R.; Davenport, D. M.; Muga, S. J.; Wargovich, M. J. Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin) Carcinogenesis 2005, 26, 1450-1456
11. Takahashi, M.; Wakabayashi, K. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents Cancer Sci. 2004, 95, 475-480
12. Hlubek, F.; Spaderna, S.; Schmalhofer, O.; Jung, A.; Kirchner, T.; Brabletz, T. Wnt/FZD signaling and colorectal cancer morphogenesis Front. Biosci. 2007, 12, 458-470
13. Kure, S.; Nosho, K.; Baba, Y.; Irahara, N.; Shima, K.; Ng, K.; Meyerhardt, J. A.; Giovannucci, E. L.; Fuchs, C. S.; Ogino, S. Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer Cancer Epidemiol. Biomarkers Prev. 2009, 18, 2765-2772
14. Pan, M. H.; Lai, C. S.; Dushenkov, S.; Ho, C. T. Modulation of inflammatory genes by natural dietary bioactive compounds J. Agric. Food Chem. 2009, 57, 4467-4477
15. Rao, C. V.; Indranie, C.; Simi, B.; Manning, P. T.; Connor, J. R.; Reddy, B. S. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor Cancer Res. 2002, 62, 165-170
16. Takahashi, M.; Mutoh, M.; Kawamori, T.; Sugimura, T.; Wakabayashi, K. Altered expression of β-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis Carcinogenesis 2000, 21, 1319-1327
17. Pettit, G. R.; Grealish, M. P.; Jung, M. K.; Hamel, E.; Pettit, R. K.; Chapuis, J. C.; Schmidt, J. M. Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate J. Med. Chem. 2002, 45, 2534-2542
18. Lin, S. Y.; Chan, H. Y.; Shen, F. H.; Chen, M. H.; Wang, Y. J.; Yu, C. K. Chitosan prevents the development of AOM-induced aberrant crypt foci in mice and suppressed the proliferation of AGS cells by inhibiting DNA synthesis J. Cell Biochem. 2007, 100, 1573-1580
19. Ju, J.; Hao, X.; Lee, M. J.; Lambert, J. D.; Lu, G.; Xiao, H.; Newmark, H. L.; Yang, C. S. A γ-tocopherol-rich mixture of tocopherols inhibits colon inflammation and carcinogenesis in azoxymethane and dextran sulfate sodium-treated mice Cancer Prev. Res. 2009, 2, 143-152
20. Bird, R. P.; Good, C. K. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer Toxicol. Lett. 2000, 112-113, 395-402
21. Paulsen, J. E.; Loberg, E. M.; Olstorn, H. B.; Knutsen, H.; Steffensen, I. L.; Alexander, J. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat Cancer Res. 2005, 65, 121-129
22. Issa, A. Y.; Volate, S. R.; Muga, S. J.; Nitcheva, D.; Smith, T.; Wargovich, M. J. Green tea selectively targets initial stages of intestinal carcinogenesis in the AOM-ApcMin mouse model Carcinogenesis 2007, 28, 1978-1984
23. Smith, D. L.; Keshavan, P.; Avissar, U.; Ahmed, K.; Zucker, S. D. Sodium taurocholate inhibits intestinal adenoma formation in APCMin/+ mice, potentially through activation of the farnesoid X receptor Carcinogenesis 2010, 31, 1100-1109
24. Denkert, C.; Koch, I.; von, K. N.; Noske, A.; Niesporek, S.; Dietel, M.; Weichert, W. Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2 Mod. Pathol. 2006, 19, 1261-1269
25. Pennisi, E. How a growth control path takes a wrong turn to cancer Science 1998, 281, 1438-1441
26. Brabletz, T.; Jung, A.; Dag, S.; Hlubek, F.; Kirchner, T. β-Catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer Am. J. Pathol. 1999, 155, 1033-1038
27. Ii, M.; Yamamoto, H.; Adachi, Y.; Maruyama, Y.; Shinomura, Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis Exp. Biol. Med. (Maywood) 2006, 231, 20-27
28. Pan, M. H.; Ghai, G.; Ho, C. T. Food bioactives, apoptosis, and cancer Mol. Nutr. Food Res. 2008, 52, 43-52
29. Holt, P. R.; Mokuolu, A. O.; Distler, P.; Liu, T.; Reddy, B. S. Regional distribution of carcinogen-induced colonic neoplasia in the rat Nutr. Cancer 1996, 25, 129-135
30. Rao, C. V.; Hirose, Y.; Indranie, C.; Reddy, B. S. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids Cancer Res. 2001, 61, 1927-1933
31. Chambers, A. F.; Matrisian, L. M. Changing views of the role of matrix metalloproteinases in metastasis J. Natl. Cancer Inst. 1997, 89, 1260-1270
32. Brabletz, T.; Jung, A.; Hermann, K.; Gunther, K.; Hohenberger, W.; Kirchner, T. Nuclear overexpression of the oncoprotein β-catenin in colorectal cancer is localized predominantly at the invasion front Pathol. Res. Pract. 1998, 194, 701-704